Kylea Potvin

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 627 citations · Full text

First-line Therapy, Urology, Chemotherapy Versus Chemotherapy +7

External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial

Timothy J. Whelan, Jim A. Julian, Tanya Berrang et al. · The Lancet · 2019 · 407 citations

Surgical Oncology, Breast Oncology, Radiation Therapy +11

A phase II randomized clinical trial of the effect of metformin versus placebo on progression-free survival in women with metastatic breast cancer receiving standard chemotherapy

Isabel Pimentel, Ana Elisa Lohmann, Marguerite Ennis et al. · The Breast · 2019 · 97 citations

Metastatic Breast Cancer, Oncology, Breast Oncology +9

CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapy

Wendy A. Teft, Inna Y. Gong, B. Dingle et al. · Breast Cancer Research and Treatment · 2013 · 77 citations

Medicine, Tamoxifen Therapy, Vitamin D Status +4

Concurrent Neoadjuvant Chemotherapy and Radiation Therapy in Locally Advanced Breast Cancer

Muriel Brackstone, David A. Palma, Alan B. Tuck et al. · International Journal of Radiation Oncology*Biology*Physics · 2017 · 63 citations

Breast Oncology, Radiation Therapy, Medicine +7